KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Taxes (2016 - 2025)

Amgen has reported Change in Taxes over the past 17 years, most recently at -$365.0 million for Q4 2025.

  • Quarterly results put Change in Taxes at -$365.0 million for Q4 2025, down 788.68% from a year ago — trailing twelve months through Dec 2025 was -$2.1 billion (down 104.55% YoY), and the annual figure for FY2025 was -$2.1 billion, down 104.55%.
  • Change in Taxes for Q4 2025 was -$365.0 million at Amgen, down from $610.0 million in the prior quarter.
  • Over the last five years, Change in Taxes for AMGN hit a ceiling of $610.0 million in Q3 2025 and a floor of -$2.4 billion in Q2 2025.
  • Median Change in Taxes over the past 5 years was $52.5 million (2021), compared with a mean of -$280.6 million.
  • Biggest five-year swings in Change in Taxes: soared 511.54% in 2022 and later crashed 5578.57% in 2024.
  • Amgen's Change in Taxes stood at -$135.0 million in 2021, then fell by 14.81% to -$155.0 million in 2022, then tumbled by 1209.03% to -$2.0 billion in 2023, then surged by 102.61% to $53.0 million in 2024, then tumbled by 788.68% to -$365.0 million in 2025.
  • The last three reported values for Change in Taxes were -$365.0 million (Q4 2025), $610.0 million (Q3 2025), and -$2.4 billion (Q2 2025) per Business Quant data.